猪CAPN1基因部分外显子及3'UTR区的SNPs检测

以野猪.民猪和大白猪为研究对象,根据网上公布的序列设计了7对引物,采用测序,PCR-SSCP和PCR-RFLP方法对CAPN1基因的部分外显子和3'UTR区进行了单核苷酸多态性检测和基因型分析,探讨CAPN1基因多态性与瘦肉率和嫩度的关系.研究发现11个SNPs,其中5个位于外显子,4个位于内含子,2个位于3'UTR区,外显子中的突变有一处是错义突变,导致了蛋白质多肽链第260位氨基酸发生了M/V的替代.群体遗传学分析表明,在所检测的各多态位点上,野猪、民猪、大白猪3个品种间不同基因型的分布都存在着极显著的差异(P<0.01),而野猪和民猪之间各基因型的分布差异不显著(P>0.05),民猪和大白猪之间各基因型的分布存在着极显著的差异(P<0.01).结合品种特性分析表明,P4、P6引物和3'UTR区Hinf1位点所检测的不同基因型和瘦肉率具有一定的相关性.     

山羊生长激素基因5调控区的多态性分析

以鲁北白山羊、引进波尔山羊、纯繁波尔山羊以及鲁北白山羊与波尔山羊的杂交一代、回交一代共计274个个体为研究材料,用两对引物分别扩增山羊生长激素(GH)基因5^'区的26－239bp以及225－429bp片段,扩增产物经SSCP分析发现均存在多态性。在26－239bp片段上,波尔山羊及杂交后代以 AA型个体占多数,而鲁北白山羊则BB型个体较多;在225－429bp片段上,所有种群均以 CC型个体较多。对两个片段的纯合型（AA,BB;CC,DD）分别克隆测序发现：（1）26－239bp片段上AA型在第60位发生了C→T的突变,第211位发生碱基C的丢失,（2）225－429bp片段上,DD型存在3处突变,分别为264位由T→C,292位由T→A,372位由C→T。上述结果为首次实验证实山羊生长激素5^'调控区存在序列多态性。     

牛HTR1B基因的分子遗传特性研究

用PCR-SSCP技术研究了涉及肉牛和奶牛共计7品种HTR1B基因的编码区和3′侧翼区的多态性,以期为牛性情的标记辅助选择积累数据。扩增得到4个片段, 有3个片段存在(SSCP)多态性。对不同的SSCP带型对应片段进行测序, 共发现6个SNP多态位点(G205T、C507T、C546G、C744T、G816A和G942A)。各遗传群体内G205T、C744T、G816A和G942A 位点均处于Hardy-Weinberg平衡, 而C507T和C546G位点只有鲁西牛处于Hardy-Weinberg平衡。奶牛205T等位基因频率显著高于其他肉牛品种(χ2 = 6.87)。奶牛G205T位点多态信息含量为0.25, 其余各位点在不同群体内均小于0.10, 说明牛HTR1B基因较保守。     

山猪群体钙调蛋白酶抑制蛋白基因遗传变异研究

目的：研究猪钙调蛋白酶抑制蛋白（CAST）基因在山猪群体的遗传变异情况,为山猪肉质研究奠定基础。方法：应用PCR-SSCP技术和测序方法检测山猪及其杂种猪CAST基因的遗传多态性,并与其他品种猪相应序列进行比较。结果：用pCT1引物在山猪及其杂种群体中检测到2个多态位点（A,B）,用pCT2引物检测到3个多态位点（C,D,E）;序列分析表明,C和E位点共同拥有6处变异。结论：通过与其他猪品种比较,发现山猪的CASTMsp基因型分布与梅山猪的基因型分布完全一样,而与国外品种猪的基因型分布差异明显。     

鼻咽癌患者的Smad2/4基因突变分析

利用PCR—SSCP银染技术对30例鼻咽癌患的Smad2／4基因的所有外显子进行突变分析,以探讨Smad2/4基因与鼻咽癌发病的可能相互关系。结果在所有病例的所有外显子上没有发现任何类型的突变。Smad2/4基因可能不是鼻咽癌的易感基因,TGF-β／Smad2/4信号通路可能不参与鼻咽癌的发病。     

Description of a simple multiplex PCR-SSCP method for AB0 genotyping and its application to the peopling of the Canary Islands

A simple and affordable multiplex polymerase chain reaction-single-strand conformation polymorphism method is proposed for the molecular study of AB0 polymorphisms. Application of this method to the peopling of the Canary Islands, analyzing a total of 2,200 chromosomes, detected that in addition to Berbers and Basques, the rare alleles 0210 and O303 are also present in the Iberian Peninsula and in the Canary Islands. Allele B101, with the highest frequency in Northwest (NW) Africa, shows a negative correlation (R = -0.822, p = 0.023) between geographic distances from this continent and insular frequencies, congruent with a main aborigine colonization from East to West still detectable today. Similar to previous autosomal studies, admixture estimations point to a major Iberian contribution (82 +/- 0.5%) to the Canary Islands, although, in some islands as La Gomera, the NW African component raised to 62 +/- 4.3%.     

In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase

Human thiopurine S-methyltransferase (TPMT) is an enzyme responsible for the detoxification of widely used thiopurine drugs such as azathioprine (Aza). Its activity is inversely related to the risk of developing severe hematopoietic toxicity in certain patients treated with standard doses of thiopurines. DNA samples from four leucopenic patients treated with Aza were screened by PCR-SSCP analysis for mutations in the 10 exons of the TPMT gene. Four missense mutations comprising two novel mutations, A83T (TPMT*13, Glu(28)Val) and C374T (TPMT*12, Ser(125)Leu), and two previously described mutations, G430C (TPMT*10, Gly(144)Arg) and T681G (TPMT*7, His(227)Gln) were identified. Using a recombinant yeast expression system, kinetic parameters (K(m) and V(max)) of 6-thioguanine S-methylation of the four TPMT variants were determined and compared to those obtained with wild-type TPMT. This functional analysis suggests that these rare allelic variants are defective TPMT alleles. The His(227)Gln variant retained only 10% of the intrinsic clearance value (V(max)/K(m) ratio) of the wild-type enzyme. The Ser(125)Leu and Gly(144)Arg variants were associated with a significant decrease in intrinsic clearance values, retaining about 30% of the wild-type enzyme, whereas the Glu(28)Val variant produced a more modest decrease (57% of the wild-type enzyme). The data suggest that the sporadic contribution of the rare Glu(28)Val, Ser(125)Leu, Gly(144)Arg, and His(227)Gln variants may account for the occurrence of altered metabolism of TPMT substrates. These findings improve our knowledge of the genetic basis of interindividual variability in TPMT activity and would enhance the efficiency of genotyping methods to predict patients at risk of inadequate responses to thiopurine therapy.     

Single nucleotide polymorphism analysis and functional characterization of the human Ah receptor (AhR) gene promoter

The aryl hydrocarbon receptor (AhR) mediates biological and toxicological actions of e.g., halogenated aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin. Although much is known about the biochemical and molecular mechanisms of AhR action, little is known about the control of the expression of the AhR gene itself. Therefore, we aimed at the identification and characterization of regions important for constitutive AhR gene expression. First, we screened 2.6 kb of the 5(')-flanking region of the AhR gene in 91 healthy Caucasian volunteers for naturally occurring genetic variants. Seven variants were detected. However, they do not seem to influence AhR gene expression in lymphocytes. Using a 2.7 kb AhR promoter luciferase reporter gene construct and various deletion constructs, a putative regulatory region was identified and characterized further by electrophoretic mobility shift assays and site-directed mutagenesis. These investigations were confirmed by cotransfection experiments in Drosophila SL2 cells. The obtained results prove an involvement of Sp1 in AhR gene regulation.     

A novel mutation of the human 7-dehydrocholesterol reductase gene reduces enzyme activity in patients with holoprosencephaly

Defects in cholesterol biosynthesis genes are recognized as a leading cause for holoprosencephaly (HPE). Previous reports suggest that mutations of human 7-dehydrocholesterol reductase (Dhcr7), which catalyzes the final step of cholesterol biosynthesis, may cause HPE [Clin. Genet. 53 (1998) 155]. To determine whether Dhcr7 mutations are involved in HPE pathogenesis, we analyzed the sequence of exon 9, which contains both a catalytic domain and a mutational hot spot. We examined 36 prematurely terminated fetuses with HPE at their gestation ages in the range from 21 to 33 weeks by single strand conformation polymorphism analysis and DNA sequencing. A novel missense mutation was identified: G344D. Dhcr7 enzyme assays using overexpressed recombinant mutant proteins revealed altered enzyme activity. Mutant G344D harbored less than 50% of enzyme activity compared with the control. Two previously reported mutations, R404C and G410S, abolished enzyme activity. These results suggest that mutation of the Dhcr7 gene is involved in HPE pathogenesis.